To evaluate the in vivo effects of DUSP4 deficiency on Lenvatinib resistance, HCC cells (NC-sgRNA and DUSP4-sgRNA) were subcutaneously inoculated into nude mice in four groups. Here, DUSP4 is linked to hepatocellular carcinoma.